Publications

Background & aims: Non-alcoholic fatty liver disease (NAFLD) is a common liver disorder with non-alcoholic steatohepatitis (NASH) being a more progressive phenotype associated with progression to cirrhosis. Type III collagen is a main component of the fibrotic extracellular matrix. PRO-C3 is a b...

Read the publication

• Extracellular Matrix Research
• Biomarker Insights
• Liver Fibrosis
• Non-Alcoholic Steatohepatitis
• Biomarkers

Abstract Background: Idiopathic pulmonary fibrosis (IPF) is characterized by the accumulation of fibrillar collagens in the alveolar space resulting in reduced pulmonary function and a high mortality rate. Biomarkers measuring the turnover of type I and III collagen could provide valuable informa...

Read the publication

• Idiopathic Pulmonary Fibrosis

Background & aims: Progressive fibrosis has been identified as the major predictor of mortality in patients with non-alcoholic fatty liver disease (NAFLD). Several biomarkers are currently being evaluated for their ability to substitute the liver biopsy as the reference standard. Recent clinical...

Read the publication

• Liver Fibrosis
• Biomarker Insights
• Fibrosis
• Non-Alcoholic Fatty Liver Disease
• Non-Alcoholic Steatohepatitis

Background The signalling peptide endotrophin is derived through proteolytic cleavage of the carboxyl-terminal during formation of type VI collagen. It is expressed by most descendants of the mesenchymal stem cells lineage, including adipocytes and fibroblasts, and have been proposed to be a centra...

Read the publication

• Endotrophin
• Extracellular Matrix Research

Rheumatoid arthritis (RA) is a chronic inflammatory disease with fluctuating course of progression. Despite substantial improvement in treatments in recent years, treatment response is still not guaranteed. The aim of this study was to identify variation in Disease Activity Score 28 (DAS28) of RA pa...

Read the publication

• Rheumatoid arthritis
• Rheumatology